XFOR X4 Pharma: Earnings per share for the last twelve months
The success of X4 Pharmaceuticals (XFOR) is based on regulatory approval of therapies for rare pathologies and insurance coverage. A monopoly in the treatment of WHIM syndrome provides the company with exceptional pricing power, while R&D relies on third-party contractors (CRO/CMO). Historical dynamics on the GURU.Markets chart for net income per share over 12 months show a trend where the -0.66 mark characterizes this parameter.
Analytical breakdowns and data insights for company X4 Pharmaceuticals Inc. (XFOR)
- current quotes and average value forecast:
- company stock capitalization data:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital X4 Pharmaceuticals|XFOR - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio X4 Pharma|XFOR - Company Aggregate Debt|Debt to Book Value Ratio X4 Pharmaceuticals, Inc.|XFOR - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings X4 Pharmaceuticals|Critical Liquidity Ratio x4pharma.com
- earnings and valuation multiples indicators:
XFOR - Net Profit|Expected Net Income X4 Pharmaceuticals|XFOR - P/E Multiple|Forward P/E Multiple X4 Pharmaceuticals, Inc.|XFOR - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation X4 Pharmaceuticals, Inc.|XFOR - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months X4 Pharmaceuticals|XFOR - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth x4pharma.com|XFOR - Earnings growth in current year|Expected earnings per share growth for next year X4 Pharmaceuticals
Fundamental valuation:X4 Pharmaceuticals
EPS TTM measures the actual profit generation efficiency available to the holder of a single security. Analyzing the net income per share over the trailing twelve months (TTM) allows investors to filter out volatility and identify the long-term earnings trend. The metric is calculated as the ratio of total annual net income to the number of shares outstanding. For X4 Pharmaceuticals (XFOR), this reflects the value of R&D investments. A stable core of scientists and the hiring of commercial experts provide the foundation for the future growth of this metric.
Competitor analysis
ARGX - Earnings per share for the last twelve months|biontech.de (BNTX) - Net earnings per share for the last 12 months|Abivax Pharma (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics Inc|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) Immunovant Therapeutics|Earnings per share for the last twelve months Kiniksa Pharmaceuticals (KNSA)|grifols.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ADPT (Adaptive Biotechnologies Corporation)|Celldex Therapeutics Inc (CLDX) - Net earnings per one share for the last twelve months|AUPH: Net earnings per share for the last 12 months|BCRX (BioCryst Corp) - Earnings per share for the last 12 months|Earnings per share for the last 12 months Vera Therapeutics, Inc.|Net earnings per share for the last 12 months dianthustx.com|PHVS - Earnings per share for the trailing year|Earnings per share for the last twelve months ABCL|TRML - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) Precigen Corp (PGEN)|Earnings per share for the trailing year Pharming Group N.V.|Net earnings per share (EPS TTM) nektar.com NKTR|Upstream Bio - Net earnings per share (EPS TTM)|ZBIO: Earnings per share for the last twelve months|Earnings per share for the trailing year Immunome Corp IMNM|GOSS (Gossamer Bio Corp.) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months KALV|Net earnings per share (EPS TTM) septerna.com|Net earnings per share (EPS TTM) PVLA|Net earnings per share (EPS TTM) Savara Inc (SVRA)|Rigel Pharmaceuticals Inc - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) AnaptysBio Inc. ANAB|ATXS (Astria Therapeutics) - Net earnings per one share for the last twelve months|engene.com (ENGN) - Net earnings per share for the last 12 months|RAPT: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Aerovate Therapeutics|Aclaris (ACRS) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) Kyverna Therapeutics, Inc|TLSA (Tiziana Life Sciences) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) cabalettabio.com (CABA)|Ventyx Biosciences, Inc. - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Theratechnologies, Inc. THTX|Avalo Therapeutics Inc. - Net earnings per share (EPS TTM)|ELDN: Earnings per share for the last twelve months|Agenus (AGEN) - Earnings per share for the last twelve months|CLYM (climbbio.com) - Earnings per share for the last twelve months|ZURA: Net earnings per share for the last four quarters|Net earnings per share for the last 12 months aTyr Pharma Inc (ATYR)|Earnings per share for the last 12 months Adagene ADAG|Net earnings per share (EPS TTM) ikenaoncology.com (IMA)|Shattuck Labs (STTK) - Earnings per one share for the last 12 months|Equillium Inc - Earnings per share for the last twelve months|CNTB (Connect Pharma) - Net earnings per one share for the last twelve months|IMUX: Earnings per share for the last twelve months|Earnings per share for the trailing year atarabio.com ATRA|IFRX (InflaRx) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months Adicet Bio Inc. ACET|Net earnings per share (EPS TTM) Celularity Corp|INmune Bio (INMB) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) Barinthus Biotherapeutics PLC (BRNS)|Net earnings per share (EPS TTM) KZR (Kezar Life Sciences, Inc)|SAB Biotherapeutics Inc - Earnings per share for the last twelve months|Earnings per share for the trailing year Akari Therapeutics (AKTX)|ENLV: Earnings per share for the last twelve months|QTTB (q32bio.com) - Net earnings per share for the last 12 months|GeoVax Labs (GOVX) - Net earnings per share (EPS TTM)|EDSA (Edesa) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months iBio Corporation (IBIO)|Carisma Therapeutics (CARM) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) xtlbio.com (XTLB)|Net earnings per share for the last four quarters BOLT|HCW Biologics, Inc. - Earnings per share for the last twelve months|APVO: Net earnings per share for the last 12 months|AIM: Earnings per share for the last twelve months|ADTX (aditxt.com) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months gribio.com|XRTX (XORTX Therapeutics) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months HIND|Earnings per share for the last 12 months Revelation Bio REVB|Net earnings per share (EPS TTM) Indaptus Corp (INDP)|SCNI: Net earnings per one share for the last twelve months|CALI - Net earnings per share for the last 12 months|Affimed Therapeutics (AFMD) - Earnings per share for the last 12 months|ALLK (Allakos Inc.) - Earnings per share for the last 12 months|HOOK (hookipapharma.com) - Net earnings per share for the last 12 months|IGM Biosciences - Earnings per share for the trailing year|Earnings per share for the last twelve months iTeos Therapeutics|oceanbiomedical.com - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) TCBP|THRD (Third Harmonic Bio Inc.) - Earnings per share for the trailing year
